by Richard Daverman, PhD
September 12, 2013 -- Sinopharm and China NT Pharma Group will form a special purchase vehicle with capital of 200 million RMB ($33 million). The SPV will make acquisitions as a means of building a specialized vaccine and cold-chain drug distribution operation in the Shanghai area. China NT Pharma, like Sinopharm, is involved in drug distribution. Sinopharm will own 60% of the SPV and China NT will own the remaining 40%. More details....
Stock Symbols: (HK: 1099) (HK: 1011)
Help employers find you! Check out all the jobs and post your resume.
